Modulation of circulating protein biomarkers following TRC105 (anti-endoglin antibody) treatment in patients with advanced cancer. (Q33913556)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Modulation of circulating protein biomarkers following TRC105 (anti-endoglin antibody) treatment in patients with advanced cancer. |
scientific article |
Statements
Modulation of circulating protein biomarkers following TRC105 (anti-endoglin antibody) treatment in patients with advanced cancer (English)
Yingmiao Liu
Mark D Starr
John C Brady
Andrew Dellinger
Bonne Adams
Charles P Theuer
Nam Y Lee
Herbert I Hurwitz
1 reference
1 reference
1 reference